Clinical trial
N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
NCT00692718 is registered in ClinicalTrials.gov with Osaka General Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
- Lead sponsor
- Osaka General Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2008
- Completion date
- Not reported
- Enrollment
- 160 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure, acute myocardial infarction